how much weight can you lose microdosing semaglutide GLP 1 Enhance Fat Loss During the Fitness Definition Phase? People are 'microdosing' weight-loss drugs.

Future clinical trials should include larger sample sizes and longitudinal monitoring in individuals with obesity who do not have diabetes

Reflux is a common sleep disruptor because lying flat can make symptoms more noticeable

A study published last year, in which people took the diabetes drug tirzepatide (sold under the brand name Mounjaro), found that a majority of those on the highest dose had a reduction in body weight of 20% or more after 72 weeks

Semaglutide is a glucagon-like peptide-1 (GLP-1) analogue, which mimics the effects of the natural GLP-1 hormone in the body, regulating blood sugar levels and appetite

This concept of microdosing GLP-1s gained traction due to obesity drug shortages shortly after these new, highly effective medications were approved in 2021 and 2022